I read the article that herro posted yesterday and I thought that I'd do a little bit of research on the Editor who wrote the piece and mentioned VitroGro.
Dr Nan Fuchs is a PHD and is an authority on nutrition and the editor of Women's Health Letter, a leading health advisory on nutritional healing for women. "She is the author of many best selling books.... Dr Fuch's appears frequently on television and radio as an expert on the topics of nutrition, herbs, acupuncture, massage and stress reduction and has been a researcher and author of dozens of articles for medical journals and consumer magazines." (Source http:www.healthy.net/scr/bio.aspx?Id=104 )
"Dr Fuchs co-founded one of the first holistic health centers in the United States in 1976. She is the author of eight books....Dr Fuchs has also appeared on more than 100 television and radio programs, where she advises listeners on nutrition, supplements and herbs and other popular health topics." (Source: http://www.advancedbionutritionals.com/Home/Nan-K-Fuchs-Bio.htm )
I'm quite aware that Tissue Therapies hasn't even launched VitroGro in the UK and Northern Europe yet and that it will need to be trialed and approved in the US before it can go on sale. However, if the early indications of the trial prove that VitroGro is a superior product (which as investors in TIS we already know), then the weight of consumer and medical desire for VitroGro will surely lead to an earlier than otherwise launch in the US.
I certainly don't see any "downside" to a high profile health practitioner "spreading the word" about VitroGro in the US. I do take revreboot's point however, that Dr Fuchs might just be a little early in adopting VitroGro.
Looking forward to EU approval for sale, hopefully in the next week or two at the latest.
Regards,
Goggo
TIS Price at posting:
35.0¢ Sentiment: LT Buy Disclosure: Held
